Elevated plasma levels of interleukin-1 receptor antagonist are associated with decreased cellular BCL-2 oncoprotein expression in B-chronic lymphocytic leukemia

Cancer Biotherapy and Radiopharmaceuticals

Volumn 13, Issue 5, 1998, Pages 383-385

  Duensing, Stefan ^a   Nasarek, Anette ^a   Grosse, Jens ^a   Ganser, Arnold ^a   Atzpodien, Jens ^a  

^a LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

B chronic lymphocytic leukemia; BCL 2 oncoprotein; Interleukin 1 receptor antagonist

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PROTEIN BCL 2;

ADULT; AGED; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE PRODUCTION; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MALE; MONONUCLEAR CELL; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032438671     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.1998.13.383     Document Type: Article

References (10)

1. Dinarello CA. Biologic basis for interleukin-2 in disease. Blood 1996;87:2095-2147.
2. Montserrat E, Rozman C. Chronic lymphocytic leukemia: prognostic factors and natural history. In: Bailliere's Clinical Hematology. Rozman C (Ed.): Chronic Lymphocytic Leukemia and Related Disorders. 1994;Vol. 6(4):849-866.
3. Francia di Celle P, Mariani S, Riera L, Stacchini A, Reato G, Foa R. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood 1996;10:4382-4389.
4. Hoffbrandt AV, Panayiotidis P, Reittie J, Ganeshaguru K. Autocrine and paracrine growth loops in chronic lymphocytic leukemia. Sem Hematol 1993;30:306-317.
5. Jewell AP, Worman CP, Lydyard PM, Yong KL, Giles FJ, Goldstone AH. Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo. Br J Haematol 1994;88:268-274.
6. Panayiotidis P, Ganeshaguru K, Jabbar SAB, Hoffbrand AV. Interleukin-2 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukemia cells in vitro. Br J Haematol 1993;85:439-445.
7. Schena M, Larsson L, Gottardi D, Gaidano G, Carlsson M, Nilsson K, Caligaris-Cappio F. Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Blood 1992;79:2981-2989.
8. + B-cell apoptosis: co-incidence of cell death and DNA fragmentation with reduced bcl-2 expression. Br J Haematol 1996;92:950-953.
9. Schmid C, Isaacson PG. Proliferation centres in B-cell malignant lymphoma, lymphocytic (B-CLL): an immunophenotypic study. Histopathology 1994;24:445-451.
10. Shin SS, Traweek T, Ulich TR. Expression of interleukin-1 receptor antagonist protein in malignant lymphomas. Arch Pathol Lab Med 1995;119:247-251.